Similar articles for PMID: 28820036

Year	Number of Results
1999	1
2002	1
2003	2
2004	4
2006	1
2007	2
2008	5
2009	6
2010	2
2011	3
2012	3
2013	6
2014	11
2015	8
2016	10
2017	15
2018	9
2019	17
2020	21
2021	12
2022	37
2023	18
2024	5

1

Efficacy and Safety of the Early Addition of Vasopressin to Norepinephrine in Septic Shock.

Hammond DA, Cullen J, Painter JT, McCain K, Clem OA, Brotherton AL, Chopra D, Meena N. Hammond DA, et al. J Intensive Care Med. 2019 Nov-Dec;34(11-12):910-916. doi: 10.1177/0885066617725255. Epub 2017 Aug 18. J Intensive Care Med. 2019. PMID: 28820036

2

Prospective Open-label Trial of Early Concomitant Vasopressin and Norepinephrine Therapy versus Initial Norepinephrine Monotherapy in Septic Shock.

Hammond DA, Ficek OA, Painter JT, McCain K, Cullen J, Brotherton AL, Kakkera K, Chopra D, Meena N. Hammond DA, et al. Pharmacotherapy. 2018 May;38(5):531-538. doi: 10.1002/phar.2105. Epub 2018 Apr 30. Pharmacotherapy. 2018. PMID: 29600824 Clinical Trial.

3

A comparison of initial monotherapy with norepinephrine versus vasopressin for resuscitation in septic shock.

Daley MJ, Lat I, Mieure KD, Jennings HR, Hall JB, Kress JP. Daley MJ, et al. Ann Pharmacother. 2013 Mar;47(3):301-10. doi: 10.1345/aph.1R442. Epub 2013 Feb 27. Ann Pharmacother. 2013. PMID: 23447481

4

Discontinuation of Vasopressin Before Norepinephrine in the Recovery Phase of Septic Shock.

Hammond DA, McCain K, Painter JT, Clem OA, Cullen J, Brotherton AL, Chopra D, Meena N. Hammond DA, et al. J Intensive Care Med. 2019 Oct;34(10):805-810. doi: 10.1177/0885066617714209. Epub 2017 Jun 15. J Intensive Care Med. 2019. PMID: 28618919

5

Efficacy and Outcomes After Vasopressin Guideline Implementation in Septic Shock.

Wu JY, Stollings JL, Wheeler AP, Semler MW, Rice TW. Wu JY, et al. Ann Pharmacother. 2017 Jan;51(1):13-20. doi: 10.1177/1060028016669163. Epub 2016 Oct 1. Ann Pharmacother. 2017. PMID: 27630192

6

Effect of Early Vasopressin vs Norepinephrine on Kidney Failure in Patients With Septic Shock: The VANISH Randomized Clinical Trial.

Gordon AC, Mason AJ, Thirunavukkarasu N, Perkins GD, Cecconi M, Cepkova M, Pogson DG, Aya HD, Anjum A, Frazier GJ, Santhakumaran S, Ashby D, Brett SJ; VANISH Investigators. Gordon AC, et al. JAMA. 2016 Aug 2;316(5):509-18. doi: 10.1001/jama.2016.10485. JAMA. 2016. PMID: 27483065 Free article. Clinical Trial.

7

Vasopressin versus norepinephrine infusion in patients with septic shock.

Russell JA, Walley KR, Singer J, Gordon AC, Hébert PC, Cooper DJ, Holmes CL, Mehta S, Granton JT, Storms MM, Cook DJ, Presneill JJ, Ayers D; VASST Investigators. Russell JA, et al. N Engl J Med. 2008 Feb 28;358(9):877-87. doi: 10.1056/NEJMoa067373. N Engl J Med. 2008. PMID: 18305265 Free article. Clinical Trial.

8

Fixed-dose vasopressin compared with titrated dopamine and norepinephrine as initial vasopressor therapy for septic shock.

Hall LG, Oyen LJ, Taner CB, Cullinane DC, Baird TK, Cha SS, Sawyer MD. Hall LG, et al. Pharmacotherapy. 2004 Aug;24(8):1002-12. doi: 10.1592/phco.24.11.1002.36139. Pharmacotherapy. 2004. PMID: 15338849

9

Hemodynamic Instability Secondary to Vasopressin Withdrawal in Septic Shock.

Bissell BD, Magee C, Moran P, Bastin MLT, Flannery AH. Bissell BD, et al. J Intensive Care Med. 2019 Sep;34(9):761-765. doi: 10.1177/0885066617716396. Epub 2017 Jul 28. J Intensive Care Med. 2019. PMID: 28750598

10

Effect of Body Weight on Hemodynamic Response in Patients Receiving Fixed-Dose Vasopressin for Septic Shock.

Hodge EK, Hughes DW, Attridge RL. Hodge EK, et al. Ann Pharmacother. 2016 Oct;50(10):816-23. doi: 10.1177/1060028016656384. Epub 2016 Jun 23. Ann Pharmacother. 2016. PMID: 27340145

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Results by year

Text availability

Article attribute

Article type

Publication date

165 results

Results by year